Spinout News

Endomag's breast cancer probe recommended to the NHS

18 May 2022

Endomag Logo

Draft guidance from NICE (National Institute for Health and Care Excellence) has recommended Endomag’s Sentimag probe for the NHS.

Sentimag detects a magnetised liquid, Magtrace, which is injected into the tissue around the cancer. It tracks the fluid’s journey – bleeping as it moves over the skin – to show where cancer may have seeded. A surgeon can then sample or biopsy the region to check if cancer is present.

Over 160,000 women, in more than 600 hospitals have received a better standard of breast surgery thanks to Endomag’s technologies.

Read the full story from BBC here.